NPCE

NeuroPace, Inc. · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website neuropace.com
Employees(FY) 169
ISIN US6412881053

Performance

+5.68%

+25.6%

+56.02%

+77.38%

+11.83%

YTD

+24.38%

Profile

NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. The company's RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip leads and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Advanced Technical Analysis

Technical Analysis of NPCE 2024-12-20

The stock exhibits a strong bullish sentiment with a Moving Average Score of 96, indicating robust upward momentum, while the Technical Score of 75 further supports this positive outlook. However, the Oscillators Score of 53 suggests a neutral stance, indicating potential consolidation or a pause in the upward trend, which investors should monit...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of NPCE

Stock Rank

Recent News & Updates

2024-12-18 03:05
NeuroPace to Present at the 43rd Annual J.P. Morgan Healthcare Conference(Globenewswire)
2024-12-12 03:05
NeuroPace to Host Investor Day on January 28th in New York City(Globenewswire)
2024-12-05 20:55
Wall Street Analysts Think NeuroPace (NPCE) Could Surge 31.47%: Read This Before Placing a Bet(Yahoo Finance)
2024-12-04 03:05
NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting(Globenewswire)
2024-12-03 03:05
NeuroPace Completes Enrollment in Feasibility Study of RNS System for Lennox-Gastaut Syndrome(Globenewswire)
2024-11-17 23:00
What Makes NeuroPace (NPCE) a New Buy Stock(Yahoo Finance)
2024-11-17 20:55
Wall Street Analysts Believe NeuroPace (NPCE) Could Rally 54.34%: Here's is How to Trade(Yahoo Finance)
2024-11-12 13:18
NeuroPace Inc (NPCE) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ...(Yahoo Finance)
2024-11-12 05:00
NeuroPace, Inc. (NPCE) Reports Q3 Loss, Tops Revenue Estimates(Yahoo Finance)
2024-11-12 03:54
NeuroPace Inc.: Q3 Earnings Snapshot(Yahoo Finance)
2024-11-12 03:05
NeuroPace Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance(Globenewswire)
2024-11-10 18:18
Earnings To Watch: NeuroPace Inc (NPCE) Reports Q3 2024 Result(Yahoo Finance)
2024-11-04 03:05
NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy(Globenewswire)
2024-10-28 09:08
KCK LTD.'s Strategic Reduction in NeuroPace Inc Shares(Yahoo Finance)
2024-10-27 20:04
Strength Seen in NeuroPace (NPCE): Can Its 5.1% Jump Turn into More Strength?(Yahoo Finance)
2024-10-24 09:08
KCK LTD. Adjusts Stake in NeuroPace Inc(Yahoo Finance)
2024-10-22 04:05
NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024(Globenewswire)
2024-10-22 03:01
KCK LTD.'s Strategic Reduction in NeuroPace Inc Shares(Yahoo Finance)
2024-10-18 03:01
KCK LTD. Reduces Stake in NeuroPace Inc(Yahoo Finance)
2024-10-16 04:05
NeuroPace Continues to Strengthen Management Team(Globenewswire)
2024-10-03 07:04
KCK LTD. Reduces Stake in NeuroPace Inc(Yahoo Finance)
2024-09-04 04:05
NeuroPace Strengthens Management Team with Two Key Appointments(Globenewswire)
2024-08-27 04:05
NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences(Globenewswire)
2024-08-22 04:05
NeuroPace to Participate in Upcoming Healthcare Conferences in September(Globenewswire)
2024-08-19 19:37
NeuroPace (NPCE) Q2 Earnings Beat, '24 Sales View Up(Yahoo Finance)
2024-08-13 04:05
NeuroPace Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance(Globenewswire)
2024-07-23 04:05
NeuroPace to Report Second Quarter 2024 Financial Results on August 13, 2024(Globenewswire)
2024-05-14 04:05
NeuroPace to Participate in Two Healthcare Conferences in May(Globenewswire)
2024-05-12 22:46
NeuroPace, Inc. (NASDAQ:NPCE) Q1 2024 Earnings Call Transcript(Insidermonkey)
2024-05-12 18:53
Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating(Yahoo Finance)

Page 1 of 5

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.